摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(4-哌啶基)苯甲酸甲酯盐酸盐 | 936130-82-4

中文名称
4-(4-哌啶基)苯甲酸甲酯盐酸盐
中文别名
——
英文名称
methyl 4-(piperidin-4-yl)benzoate hydrochloride
英文别名
4-(4-(Methoxycarbonyl)phenyl)piperidinium chloride;methyl 4-piperidin-1-ium-4-ylbenzoate;chloride
4-(4-哌啶基)苯甲酸甲酯盐酸盐化学式
CAS
936130-82-4
化学式
C13H17NO2*ClH
mdl
——
分子量
255.744
InChiKey
RBOHZKFJKGYRPA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.36
  • 重原子数:
    17
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.46
  • 拓扑面积:
    38.3
  • 氢给体数:
    2
  • 氢受体数:
    3

安全信息

  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335

SDS

SDS:13b8f42305e0f6f8981ca86574b90ece
查看

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] PYRAZOLE DERIVATIVES WHICH INHIBIT LEUKOTRIENE PRODUCTION<br/>[FR] DÉRIVÉS DE PYRAZOLE INHIBANT LA PRODUCTION DE LEUCOTRIÈNE
    申请人:BOEHRINGER INGELHEIM INT
    公开号:WO2014014874A1
    公开(公告)日:2014-01-23
    The present invention relates to compounds of formula (I): or a pharmaceutically acceptable salt thereof, wherein A1, A2, L1 and B are as defined herein. The compounds of formula (I) are useful as inhibitors of leukotriene A4 hydrolase (LTA4H) and treating LTA4H related disorders. The present invention also relates to pharmaceutical compositions comprising the compounds of formula (I), methods of using these compounds in the treatment of various diseases and disorders, and processes for preparing these compounds.
    本发明涉及以下式(I)的化合物或其药学上可接受的盐,其中A1、A2、L1和B如本文所定义。式(I)的化合物可用作白三烯A4水解酶(LTA4H)的抑制剂,并用于治疗与LTA4H相关的疾病。本发明还涉及包含式(I)的化合物的药物组合物,使用这些化合物治疗各种疾病和疾病的方法,以及制备这些化合物的方法。
  • NOVEL COMPOUNDS
    申请人:Buttar David
    公开号:US20080153812A1
    公开(公告)日:2008-06-26
    There is provided a compound of formula (I): or a pharmaceutically acceptable salt thereof. There are also provided processes for the manufacture of a compound of Formula 1, and the use of a compound of Formula 1 as a medicament and in the treatment of cancer.
    提供了一个式(I)的化合物,或其药用可接受的盐。还提供了制备式1化合物的方法,以及将式1化合物用作药物和用于癌症治疗的用途。
  • [EN] 4, 6-DISUBSTITUTED 2-AMINO-PYRIMIDINES AS HISTAMINE H4 RECEPTOR MODULATORS<br/>[FR] 2-AMINO-PYRIMIDINES 4,6-DISUBSTITUÉES, CONVENANT COMME MODULATEURS DU RÉCEPTEUR H4 DE L'HISTAMINE
    申请人:INCYTE CORP
    公开号:WO2010075270A1
    公开(公告)日:2010-07-01
    The present invention relates to substituted heterocyclic compounds of Formula (I) or pharmaceutically acceptable salts or N-oxides or quaternary ammonium salts thereof wherein constituent members are provided hereinwith, as well as their compositions and methods of use, which are histamine H4 receptor inhibitors/antagonists useful in the treatment of histamine H4 receptor-associated conditions or diseases or disorders including, for example, inflammatory diseases or disorders, pruritus, and pain.
    本发明涉及式(I)的取代杂环化合物或其药用可接受的盐或N-氧化物或季铵盐,其中所述成员在此提供,并且它们的组合物和使用方法,这些化合物是组织胺H4受体抑制剂/拮抗剂,用于治疗组织胺H4受体相关疾病或疾病或疾病,例如,炎症性疾病或疾病,瘙痒和疼痛。
  • Therapeutic Agents - 550
    申请人:Butlin Roger John
    公开号:US20090105305A1
    公开(公告)日:2009-04-23
    A compound of formula I or a pharmaceutically acceptable salt thereof, processes for preparing such compounds, their use as Fatty Acid Synthase inhibitors, methods for their therapeutic use, particularly in the treatment of obesity and diabetes mellitus, cancer and infection and pharmaceutical compositions containing them.
    一种化学式I的化合物或其药学上可接受的盐,制备这种化合物的方法,其用作脂肪酸合成酶抑制剂,以及治疗肥胖症和糖尿病、癌症和感染的方法,以及包含它们的药物组合物。
  • N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof
    申请人:AstraZeneca AB
    公开号:US07737149B2
    公开(公告)日:2010-06-15
    There is provided a compound of formula (I): or a pharmaceutically acceptable salt thereof. There are also provided processes for the manufacture of a compound of Formula 1, and the use of a compound of Formula 1 as a medicament and in the treatment of cancer.
    提供了一个公式(I)的化合物:或其药学上可接受的盐。还提供了制造公式1化合物的方法,以及将公式1化合物用作药物和治疗癌症的用途。
查看更多